Construction and identification of the recombinant plasmid pET30a‑EgA31‑Eg95 of Echinococcus granulosus

Li,Yanhua; Zhang,Fengbo; Althunayan,Mohammed  H.; Hu,Xiao-An; Xin,Yan; Jia,Haiying; Guo,Yuyuan; Ma,Xiumin; Wen,Hao; Ding,Jianbing

doi:10.3892/etm.2013.1393

2014-January Volume 7 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-January Volume 7 Issue 1

Full Size Image

Article

Construction and identification of the recombinant plasmid pET30a‑EgA31‑Eg95 of Echinococcus granulosus

Authors:
- Yanhua Li
- Fengbo Zhang
- Mohammed H. Althunayan
- Xiao-An Hu
- Yan Xin
- Haiying Jia
- Yuyuan Guo
- Xiumin Ma
- Hao Wen
- Jianbing Ding
View Affiliations / Copyright

Affiliations: Xinjiang Laboratory of Hydatid Fundamental Medicine, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China, Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China
Pages: 204-208
|
Published online on: November 7, 2013

https://doi.org/10.3892/etm.2013.1393
Expand metrics +

Abstract

To clone the Eg95 and EgA31 antigen genes into the prokaryotic expression plasmid pET30a‑EgA31‑Eg95, we expressed the recombinant protein EgA31‑Eg95 and confirmed with western blot analysis. The total RNA was extracted from the protoscoleces of Echinococcus granulosus (E. granulosus) adult worms. The complementary DNA (cDNA) encoding the EgA31 antigen was amplified via quantitative real‑time polymerase chain reaction (qPCR). The recombinant plasmid pET30a‑EgA31 was used as a carrier and was connected with the Eg95 vector. The recombinant plasmid pET30a‑EgA31‑Eg95 was constructed and the fusion protein EgA31‑Eg95 was detected using sodium dodecyl sulfate‑polyacrylamide gel electrophoresis (SDS‑PAGE). The positive clone was the empty recombinant vector. The recombinant protein pET30a‑EgA31‑Eg95 was ~46 kDa, and the expressed product accounted for approximately 20% of the total soluble proteins. We successfully constructed the recombinant plasmid pET30a‑EgA31‑Eg95 and expressed the recombinant protein EgA31‑Eg95. The results may be the foundation of research on its immunogenicity in the future.

View Figures

View References

1	Cardona GA and Carmena D: A review of the global prevalence, molecular epidemiology and economics of cystic echinococcosis in production animals. Vet Parasitol. 192:10–32. 2013. View Article : Google Scholar : PubMed/NCBI
2	Zhang W and McManus DP: Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol. 47:24–41. 2006. View Article : Google Scholar : PubMed/NCBI
3	Heath DD, Robinson C, Shakes T, et al: Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis). Vaccine. 30:3076–3081. 2012. View Article : Google Scholar : PubMed/NCBI
4	Tomuş C, Zaharie F, Mocan L, et al: Minimal invasive treatment of abdominal multiorgan echinococcosis. Int Surg. 98:61–64. 2013.PubMed/NCBI
5	Dalton JP and Mulcahy G: Parasite vaccines - a reality. Vet Parasitol. 98:149–167. 2001. View Article : Google Scholar : PubMed/NCBI
6	Lightowlers MW, Flisser A, Gauci CG, et al: Vaccination against cysticercosis and hydatid disease. Parasitol Today. 16:191–196. 2000. View Article : Google Scholar : PubMed/NCBI
7	Barnes TS, Deplazes P, Gottstein B, et al: Challenges for diagnosis and control of cystic hydatid disease. Acta Trop. 123:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
8	Fraize M, Sarciron ME, Saboulard D, et al: An in vitro model to evaluate the cytokine response in Echinococcus infections. Parasitol Res. 92:506–512. 2004. View Article : Google Scholar : PubMed/NCBI
9	Fraize M, Sarciron ME, Azzouz S, et al: Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice. Parasitol Res. 96:113–120. 2005.
10	Vuitton DA: The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop. 85:119–132. 2003. View Article : Google Scholar : PubMed/NCBI
11	Urban JF Jr, Madden KB, Svetić A, et al: The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev. 127:205–220. 1992. View Article : Google Scholar : PubMed/NCBI
12	Ding JB, Lin RY, Wen H, et al: Cloning and eukaryotic expression plasmid construct of Echinococcus granulosus 95 (Eg95) antigen gene. The Chinese people Zoonosis magazine. 19:42–44. 2003.(In Chinese).
13	Liu XF, Ding JB, Li YJ, et al: The Echinococcus multilocularis 95 antigen T-B epitope analysis. Chinese Journal of Parasitic Disease. 7:779–773. 2012.(In Chinese).
14	Alvite G and Esteves A: Echinococcus granulosus tropomyosin isoforms: from gene structure to expression analysis. Gene. 433:40–49. 2009. View Article : Google Scholar
15	Saboulard D, Lahmar S, Petavy AF and Bosquet G: The Echinococcus granulosus antigen EgA31: localization during development and immunogenic properties. Parasite Immunol. 25:489–501. 2003.
16	Fu Y, Martinez C, Chalar C, et al: A new potent antigen from Echinococcus granulosus associated with muscles and tegument. Mol Biochem Parasitol. 102:43–52. 1999.PubMed/NCBI
17	Capron A, Capron M and Riveau G: Vaccine development against schistosomia sis from concepts to clinical trials. Br Med Bull. 62:139–148. 2002. View Article : Google Scholar : PubMed/NCBI
18	Kalinna BH and McManus DP: A vaccine against the Asian schistosome, Schistosoma japonicum: an update on paramyosin as a target of protective immunity. Int J Parasitol. 27:1213–1219. 1997.PubMed/NCBI
19	Jounai N, Kobiyama K, Takeshita F and Ishii KJ: Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front Cell Infect Microbiol. 2:1682012.PubMed/NCBI
20	McManus DP and Loukas A: Current status of vaccines for schistosomiasis. Clin Microbiol Rev. 21:225–242. 2008. View Article : Google Scholar : PubMed/NCBI
21	Nara T, Tanabe K, Mahakunkijcharoen Y, et al: The B cell epitope of paramyosin recognized by a protective monoclonal IgE antibody to Schistosoma japonicum. Vaccine. 15:79–84. 1997. View Article : Google Scholar : PubMed/NCBI
22	Esmaelizad M, Ahmadian G, Aghaiypour K, et al: Induction of prominent Th1 response in C57Bl/6 mice immunized with an E. coli-expressed multi T-cell epitope EgA31 antigen against Echinococcus granulosus. Folia Parasitol (Praha). 60:28–34. 2013. View Article : Google Scholar : PubMed/NCBI
23	Heath DD, Robinson C and Lightowlers MW: Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus. Vaccine. 30:7321–7326. 2012. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Construction and identification of the recombinant plasmid pET30a‑EgA31‑Eg95 of Echinococcus granulosus

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles